Wednesday, February 19, 2025
1PM – 2PM ET
Friends of Cancer Research (Friends) hosted a webinar designed for advocates on February 19, 2025, as a follow-up to Friends’ public meeting titled, “Advancing the Future of Diagnostics and Regulatory Innovations” on February 4, 2025.
The webinar, “Advancing the Future of Diagnostics and Regulatory Innovations Meeting Recap: Sharing Next Steps and Opportunities with Advocates,” dove into the discussions from the core event and explore implications for patient advocacy and regulatory efforts. The advocates webinar featured:
- An overview of evidence generation for digital pathology and AI technologies, presented by our diagnostics project partners and Friends Advisory Advocates.
- A discussion of findings from the Friends Digital PATH Project.
- Strategies for developing diagnostic tests for rare biomarkers, and future regulatory considerations for emerging, cutting-edge diagnostics tools.
- Q&A session with working group members from Friends’ diagnostic projects (patient advocates, researchers, and regulatory experts).
AGENDA
1:00 PM – Opening Remarks
- Mark Stewart, Friends of Cancer Research
1:05 PM – Panel Introduction & Discussion
- Megan Doyle, Eli Lilly & Company – Moderator
- George Green, GA Green Consulting LLC
- Joan Mancuso, Friends Advisory Advocate
- Alain Silk, Tempus AI
1:25 PM – Audience Q&A Session
2:00 PM – Meeting Adjourned
Draft agenda is subject to change